http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2114014-C
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate | 1992-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_853b61785e575e0be9b6242fd182ff62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de71cd00cc2267302d2c3eddec2e168c |
| publicationDate | 1999-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2114014-C |
| titleOfInvention | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
| abstract | The present invention relates to a composition and method of treating a patient by administering carbamazepine in a pharmaceutical dosage form capable of maintaining the patient's blood concentration at from about 4 µg/ml to about 12 µg/ml over at least a 12 hour period, where the blood concentration of carbamazepine does not vary by more than 60 percent. |
| priorityDate | 1991-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.